Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14502845rdf:typepubmed:Citationlld:pubmed
pubmed-article:14502845lifeskim:mentionsumls-concept:C0885057lld:lifeskim
pubmed-article:14502845lifeskim:mentionsumls-concept:C0001792lld:lifeskim
pubmed-article:14502845lifeskim:mentionsumls-concept:C0025914lld:lifeskim
pubmed-article:14502845lifeskim:mentionsumls-concept:C0026809lld:lifeskim
pubmed-article:14502845lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:14502845lifeskim:mentionsumls-concept:C0876994lld:lifeskim
pubmed-article:14502845pubmed:issue2lld:pubmed
pubmed-article:14502845pubmed:dateCreated2003-9-23lld:pubmed
pubmed-article:14502845pubmed:abstractTextProtective effects of an aged garlic extract on the cardiotoxicity of doxorubicin (DOX) was evaluated using the mouse. DOX (1.5 mg/kg body wt i.p.) was administered three times per week for 40 days. An aged garlic extract, WG-1 (a preserved stock solution; Wakunaga Pharmaceutical) was administered intraperitoneally six times weekly. DOX caused changes in the electrocardiogram. In the control mice, the width of the QRS complex was 20 +/- 2.8 milliseconds, the R-R interval was 130 +/- 2.8 milliseconds, and the P-Q interval was 30 +/- 1.4 milliseconds. In mice treated with DOX for 40 days, the width of the QRS complex was 50 +/- 10 milliseconds (p < 0.05), the R-R interval was 240 +/- 30 milliseconds (p < 0.05), and the P-Q interval was 45 +/- 1.0 milliseconds (p < 0.01). These values were significantly smaller in mice treated with WG-1 + DOX than in mice treated with DOX. The width of the QRS complex was 29.3 +/- 5.8 milliseconds (p < 0.05), the R-R interval was 145.8 +/- 17.9 milliseconds (p < 0.01), and the P-Q interval was 37.8 +/- 3.5 milliseconds (p < 0.05). The lipid peroxidation in the heart homogenates prepared from DOX-treated mice, as measured by thiobarbituric acid-reactive substance (TBARS, nmol malondialdehyde/100 mg protein) was 332.5 +/- 67.0, which was significantly larger than that in the control mice (186.6 +/- 42.2) (p < 0.05). WG-1 decreased the level of TBARS in DOX-treated mice significantly. In the mice treated with WG-1 + DOX, TBARS was 221.3 +/- 31.6, which was significantly smaller than that of DOX-treated mice (p < 0.05). Histological study demonstrated that the heart treated with DOX had vacuolization in muscle cells, disrupted myofibrils, and swollen mitochondria. Mice that received WG-1 + DOX had no significant pathological lesions in the heart.lld:pubmed
pubmed-article:14502845pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14502845pubmed:languageenglld:pubmed
pubmed-article:14502845pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14502845pubmed:citationSubsetIMlld:pubmed
pubmed-article:14502845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14502845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14502845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14502845pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14502845pubmed:statusMEDLINElld:pubmed
pubmed-article:14502845pubmed:issn0163-5581lld:pubmed
pubmed-article:14502845pubmed:authorpubmed-author:OhnishiS TSTlld:pubmed
pubmed-article:14502845pubmed:authorpubmed-author:ToyamaYYlld:pubmed
pubmed-article:14502845pubmed:authorpubmed-author:KojimaRRlld:pubmed
pubmed-article:14502845pubmed:issnTypePrintlld:pubmed
pubmed-article:14502845pubmed:volume22lld:pubmed
pubmed-article:14502845pubmed:ownerNLMlld:pubmed
pubmed-article:14502845pubmed:authorsCompleteYlld:pubmed
pubmed-article:14502845pubmed:pagination163-73lld:pubmed
pubmed-article:14502845pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:meshHeadingpubmed-meshheading:14502845...lld:pubmed
pubmed-article:14502845pubmed:year1994lld:pubmed
pubmed-article:14502845pubmed:articleTitleProtective effects of an aged garlic extract on doxorubicin-induced cardiotoxicity in the mouse.lld:pubmed
pubmed-article:14502845pubmed:affiliationPhiladelphia Biomedical Research Institute, King of Prussia, PA 19406, USA.lld:pubmed
pubmed-article:14502845pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14502845pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14502845lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14502845lld:pubmed